[Kidney disease and insulin resistance--clinical impact of thiazolidinedione compounds for kidney disease].
Isshiki, K
[Kidney disease and insulin resistance--clinical impact of thiazolidinedione compounds for kidney disease]. [electronic resource] - Nihon rinsho. Japanese journal of clinical medicine Feb 2000 - 440-5 p. digital
Publication Type: Journal Article; Review
0047-1852
Animals
Chromans--pharmacology
Diabetes Mellitus, Type 1--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Humans
Hypoglycemic Agents--pharmacology
Insulin Resistance
Kidney Diseases--drug therapy
Protein Kinase C--antagonists & inhibitors
Rats
Thiazoles--pharmacology
Thiazolidinediones
Troglitazone
[Kidney disease and insulin resistance--clinical impact of thiazolidinedione compounds for kidney disease]. [electronic resource] - Nihon rinsho. Japanese journal of clinical medicine Feb 2000 - 440-5 p. digital
Publication Type: Journal Article; Review
0047-1852
Animals
Chromans--pharmacology
Diabetes Mellitus, Type 1--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Humans
Hypoglycemic Agents--pharmacology
Insulin Resistance
Kidney Diseases--drug therapy
Protein Kinase C--antagonists & inhibitors
Rats
Thiazoles--pharmacology
Thiazolidinediones
Troglitazone